Intranasal phosphoramidon increases beta-amyloid levels in wild-type and NEP/NEP2-deficient mice

Journal of Molecular Neuroscience

Volumn 43, Issue 3, 2011, Pages 424-427

  Hanson, Leah R ^a   Hafez, Daniel ^b   Svitak, Aleta L ^a   Burns, Rachel B ^a   Li, Xuan ^b   Frey II, William H ^a   Marr, Robert A ^b  

^a REGIONS HOSPITAL   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Alzheimer's disease; Beta amyloid; Intranasal; NEP; NEP2; Phosphoramidon

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HIPPOCAMPUS; HUMAN; MOUSE; NONHUMAN; OLFACTORY BULB;

ADMINISTRATION, INTRANASAL; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; GLYCOPEPTIDES; HUMANS; MICE; MICE, KNOCKOUT; NEPRILYSIN; PROTEASE INHIBITORS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 79955844065     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9460-8     Document Type: Article

References (16)

1. Carpentier M, Guillemette C, Bailey JL, Boileau G, Jeannotte L, DesGroseillers L, Charron J (2004) Reduced fertility in male mice deficient in the zinc metallopeptidase NL1. Mol Cell Biol 24:4428-4437 (Pubitemid 41071012)
2. Danielyan L, Schafer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T, Burkhardt U, Proksch B, Verleysdonk S, Ayturan M, Buniatian GH, Gleiter CH, Frey WH 2nd (2009) Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315-324
3. Dhuria SV, Hanson LR, Frey WH 2nd (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci 99:1654-1673
4. Dolev I, Michaelson DM (2004) A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Proc Natl Acad Sci USA 101:13909-13914 (Pubitemid 39298506)
5. Hafez D, Huang JY, Huynh AM, Valtierra S, Rockenstein E, Bruno AM, Lu B, DesGroseillers L, Masliah E, Marr RA (2010) Neprilysin-2 is an important beta- amloid degrading enzyme. Am J Pathol (in press)
6. Hanson LR, Frey WH 2nd (2008) Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC Neurosci 9(Suppl 3):S5
7. Hanson LR, Martinez PM, Taheri S, Kamsheh L, Mignot E, Frey WHI (2004) Intranasal administration of hypocretin 1 (Orexin A) bypasses the blood-brain barrier & targets the brain: a new strategy for the treatment of narcolepsy. Drug Deliv Technol 4:66-71
8. Hanson LR, Roeytenberg A, Martinez PM, Coppes VG, Sweet DC, Rao RJ, Marti DL, Hoekman JD, Matthews RB, Frey WH 2nd, Panter SS (2009) Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther 330:679-686
9. Huang JY, Bruno AM, Patel CA, Huynh AM, Philibert KD, Glucksman MJ,Marr RA (2008) Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40. Neuroscience 155:258-262
10. Ikeda K, Emoto N, Raharjo SB, Nurhantari Y, Saiki K, Yokoyama M, Matsuo M (1999) Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 274:32469-32477
11. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine- Aizawa Y, Saido TC (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med 6:143-150 (Pubitemid 30082357)
12. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Abeta by neprilysin. Science 292:1550-1552 (Pubitemid 32493424)
13. Lu B, Gerard NP, Kolakowski LF Jr, Bozza M, Zurakowski D, Finco O, Carroll MC, Gerard C (1995) Neutral endopeptidase modulation of septic shock. J Exp Med 181:2271-2275
14. Marr RA, Spencer BJ (2010) NEP-like endopeptidases and Alzheimer's disease. Curr Alzheimer Res 7:223-229
15. Mouri A, Zou LB, Iwata N, Saido TC, Wang D, Wang MW, Noda Y, Nabeshima T (2006) Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory. Behav Brain Res 168:83-91 (Pubitemid 43152056)
16. Nisemblat Y, Belinson H, Dolev I, Michaelson DM (2007) Alzheimer's and Parkinson's diseases: progress and new perspectives. Abstracts of the 8th international conference AD/PD, Salzburg, Austria, March 14-18, 2007. Abstracts. Neurodegener Dis 4(Suppl 1):1-350